Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
A single dose, two treatments (two cephalexin suspension brands), two sequences, cross-over
design was used with a washout of 7 days between the two study periods. Treatment groups
balanced with the same number of healthy volunteers who were randomly (in two strata: male
and female) assigned to the study drug administration sequences